Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASCO 2019 /
Expanded clinical trial inclusion criteria would double the percentage of patients eligible to enrol in clinical trials

31st May - 4th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.06.19
Views: 506

Dr R. Donald Harvey - Winship Cancer Institute of Emory University, Druid Hills, Georgia

Dr R. Donald Harvey presents results at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting from a study looking at using ASCO’s CancerLinQ database to look expanding clinical trial inclusion criteria.

Researchers looked at 10,500 health records of advanced non-small cell lung cancer and compared the traditional criteria with the proposed new criteria from ASCO and Friends of Cancer Research.

With the traditional criteria applied 47.7% of patients would not meet trial eligibility however if the expanded criteria were adopted, only 1.5% of patients would not meet eligibility criteria.

Watch the interview here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation